1. Home
  2. UG vs NEPH Comparison

UG vs NEPH Comparison

Compare UG & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United-Guardian Inc.

UG

United-Guardian Inc.

N/A

Current Price

$7.24

Market Cap

29.9M

ML Signal

N/A

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$2.90

Market Cap

31.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UG
NEPH
Founded
1942
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.9M
31.0M
IPO Year
1995
2004

Fundamental Metrics

Financial Performance
Metric
UG
NEPH
Price
$7.24
$2.90
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
2.9K
21.6K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
7.10%
N/A
EPS Growth
N/A
1000.00
EPS
0.20
0.11
Revenue
$10,545,468.00
$18,789,000.00
Revenue This Year
N/A
$11.24
Revenue Next Year
N/A
$11.58
P/E Ratio
$35.65
$29.36
Revenue Growth
N/A
32.67
52 Week Low
$5.58
$1.78
52 Week High
$9.88
$6.42

Technical Indicators

Market Signals
Indicator
UG
NEPH
Relative Strength Index (RSI) 64.39 52.20
Support Level $6.26 $2.79
Resistance Level $7.70 $3.18
Average True Range (ATR) 0.18 0.24
MACD 0.05 0.06
Stochastic Oscillator 88.00 69.11

Price Performance

Historical Comparison
UG
NEPH

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: